Liverpool promotes biotech sector in US
LIVERPOOL is to promote the strength of its life sciences sector at a global conference for the biotechnology industry at Boston in the US.
Dr Geoff Wainwright of 2Bio Ltd and Dr Neil Murray of Redx Pharma will represent the city’s sector at the BIO International Convention, which runs for the next three days.
Dr Wainwright said: “Liverpool is a compelling proposition for investment because of our concentration of clinical, medical, educational and research assets.
“We have a unique partnership between our leading organisations, including Redx Pharma, Liverpool Vision, Liverpool City Council, our major teaching hospitals, the new Life Sciences University Technical College and our Universities in order to deliver an exciting new model of development for the life science industry.
“It will connect academic and specialist research assets to emerging technologies that have major market potential which will help propel the city as a leading international centre for life sciences. This conference is the most important place in the life sciences calendar to meet key contacts and build the right commercial relationships.”
